The U.S. government will soon spend $25 million to help patients access experimental drugs for the incurable illness known as Lou Gehrig's disease
This photo provided by ALS patient Brian Wallach shows him and his wife, Sandra Abrevaya, at their home in Chicago on May 2021. Wallach, who formed I AM ALS with Abrevaya after being diagnosed with ALS in 2017, spent years working on legislation with congressional staffers, researchers and patients which passed the House last December in a landslide 423-3 vote.
Only patients who can't get into conventional drug trials are eligible for the program. And their progress must be tracked to gather data about the treatment and their underlying disease, amyotrophic lateral sclerosis, or ALS. Up to 90% of ALS patients are ineligible for traditional clinical trials, according to researchers, typically because their disease has progressed too far to show major treatment benefits. Even eligible patients must compete for access. One recent analysis counted 2,000 trial openings in the U.S. for 25,000 people living with ALS.
The NIH spends the vast majority of its $45 billion budget on early-stage research focused on identifying the root causes, treatments and potential cures for diseases. “I’m five years in so I can’t qualify for any clinical trials,” said Brian Wallach, who launched I AM ALS with his wife after being diagnosed in 2017. “I hope to be eligible for the expanded access pathway.”
The legislation grew out of patients' deep frustration with access to experimental therapies, including a stem cell treatment from the tiny drugmaker Brainstorm Cell Therapeutics.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Best mattress topper with 49,000 5-star reviews is only $25 todayA great deal on Amazon's best mattress topper cuts the price to just $25. You'll enjoy better sleep and save a ton of money as well!
Read more »
‘Smile’ Sees $2M In Previews, ‘Don’t Worry Darling’ Ends First Week With $25.5M+ – Box OfficeParamount’s horror movie Smile struck up $2M in Thursday night previews that started at 7 p.m., a figure that’s just above M. Night Shyamalan’s Old from summer 2021, which did $1.…
Read more »
Can Dinomania Strike Twice? Christie's Is Selling a Full T. Rex Skeleton—a $25 Million Specimen Named Shen—in Hong Kong | Artnet NewsCan dinomania strike twice? Christie's is selling a full T. Rex skeleton—a $25 million specimen named Shen—in Hong Kong:
Read more »
Spectacular T. rex skeleton may fetch $25 million at auction (the new owner gets to name it, too)Laura is the archaeology/history and Life's Little Mysteries editor at Live Science. She also reports on general science, including archaeology and paleontology. Her work has appeared in The New York Times, Scholastic, Popular Science and Spectrum, a site on autism research. She has won multiple awards from the Society of Professional Journalists and the Washington Newspaper Publishers Association for her reporting at a weekly newspaper near Seattle. Laura holds a bachelor's degree in English literature and psychology from Washington University in St. Louis and a master's degree in science writing from NYU.
Read more »
NIH to fund unproven ALS drugs under patient-backed lawThe U.S. government will soon spend $25 million to help patients access experimental drugs for the incurable illness known as Lou Gehrig's disease
Read more »